Sanna Lemming

Sanna Lemming has an extensive background in medical writing, with experience at multiple companies and organizations. Sanna most recently worked as a Principal Medical Writer at Zealand Pharma, starting in 2021. Prior to that, they held the same role at Orphazyme A/S from 2019 to 2021, and also worked as a Senior Medical Writer there from 2019 to 2021. Before joining Orphazyme A/S, Sanna worked as a Senior Medical Writer at Larix - a full service Clinical CRO in 2018. Sanna also has experience as a Medical Writer at Novo Nordisk from 2013 to 2018, and at Ferring Pharmaceuticals from 2010 to 2013. Sanna began their career as a Ph.d student at Aarhus University from 2007 to 2010, and also worked as an ITM and MW at Novo Nordisk A/S in 2006.

Sanna Lemming completed their education with a Master of Science (M.Sc.) degree in Animal Behavior and Ethology and Molecular Biology from Københavns Universitet - University of Copenhagen in the years 2000 to 2005.

Sanna further pursued Neurobiology and Behavior, earning a Doctor of Philosophy (Ph.D.) degree from Aarhus University between 2007 and 2010.